A detailed history of Verition Fund Management LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 19,408 shares of BLFS stock, worth $485,394. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,408
Previous 21,639 10.31%
Holding current value
$485,394
Previous $463,000 4.75%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.19 - $26.52 $42,812 - $59,166
-2,231 Reduced 10.31%
19,408 $485,000
Q2 2024

Aug 14, 2024

BUY
$15.14 - $22.99 $327,614 - $497,480
21,639 New
21,639 $463,000
Q4 2021

Feb 14, 2022

SELL
$32.99 - $58.55 $372,885 - $661,790
-11,303 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$42.03 - $60.5 $475,065 - $683,831
11,303 New
11,303 $478,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.07B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.